Cargando…

Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma

BACKGROUND: Protease-Activated Receptor-1 (PAR-1) plays an important role in the pathogenesis of multiple malignancies and its expression strongly also affects the outcomes of cancer patients. The objective of this study was to determine the clinical significance of the serum levels of PAR-1in cutan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tas, Faruk, Bilgin, Elif, Karabulut, Senem, Erturk, Kayhan, Duranyildiz, Derya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840403/ https://www.ncbi.nlm.nih.gov/pubmed/27141440 http://dx.doi.org/10.1016/j.bbacli.2016.04.001

Ejemplares similares

Clinical Significance of Circulating Serum Cellular Heat Shock Protein 90 (HSP90) Level in Patients with Cutaneous Malignant Melanoma
por: Tas, Faruk, et al.
Publicado: (2017)

Assessment of Anxiety and Depression Status in Turkish Cutaneous Melanoma Patients
por: Tas, Faruk, et al.
Publicado: (2017)

Clinical Signifčcance of Serum Ykl-40 (Chitinase-3-Like-1 Protein) as a Biomarker in Melanoma: an Analysis of 112 Turkish Patients
por: Erturk, Kayhan, et al.
Publicado: (2017)

Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma
por: Karabulut, Senem, et al.
Publicado: (2016)

Widespread finger skin metastases of melanoma
por: Tas, Faruk, et al.
Publicado: (2018)

Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer
por: Afsar, Cigdem Usul, et al.
Publicado: (2018)

Clinical Significance of Serum Membrane-Bound Mucin-2 Levels in Breast Cancer
por: Bademler, Suleyman, et al.
Publicado: (2019)

Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer
por: KARABULUT, MEHMET, et al.
Publicado: (2015)

Evaluation of epidermal growth factor receptor serum levels and their association with clinicopathological characteristics in patients with colorectal cancer
por: Karabulut, Mehmet, et al.
Publicado: (2017)

Cutaneous melanoma
por: Négrier, S, et al.
Publicado: (2001)

Age is a prognostic factor affecting survival in lung cancer patients
por: TAS, FARUK, et al.
Publicado: (2013)

Mucosal Melanoma in the Head and Neck Region: Different Clinical Features and Same Outcome to Cutaneous Melanoma
por: Tas, Faruk, et al.
Publicado: (2013)

Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases
por: Kraehn, G M, et al.
Publicado: (2001)

Mortality from cutaneous melanoma: evidence for contrasting trends between populations
por: Severi, G, et al.
Publicado: (2000)

Lectin binding to cutaneous malignant melanoma: HPA is associated with metastasis formation
por: Thies, A, et al.
Publicado: (2001)

Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis
por: Lin, Cong, et al.
Publicado: (2015)

p21(WAF1/CIP1)expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival
por: Karjalainen, J M, et al.
Publicado: (1999)

On the clinical significance of cutaneous melanoma's precursors
por: Noto, Giuseppe
Publicado: (2012)

Prognostic significance of LKB1 promoter methylation in cutaneous malignant melanoma
por: Zhang, Weiming, et al.
Publicado: (2017)

Chemokine Receptor CXCR4 Is a Novel Marker for the Progression of Cutaneous Malignant Melanomas
por: Toyozawa, Seiko, et al.
Publicado: (2012)

Prevalence and correlates of skin self-examination practices among cutaneous malignant melanoma survivors
por: Manne, Sharon L., et al.
Publicado: (2020)

Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platelets
por: French, Shauna L., et al.
Publicado: (2016)

Effects of aerobic training on serum paraoxonase activity and its relationship with PON1-192 phenotypes in women
por: Nalcakan, Gulbin Rudarli, et al.
Publicado: (2016)

Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients
por: Kimura, M, et al.
Publicado: (1999)

Risk of cutaneous malignant melanoma in relation to use of sunbeds: further evidence for UV-A carcinogenicity
por: Westerdahl, J, et al.
Publicado: (2000)

p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis
por: Zerp, S F, et al.
Publicado: (1999)

Histone 2B Facilitates Plasminogen-Enhanced Endothelial Migration through Protease-Activated Receptor 1 (PAR1) and Protease-Activated Receptor 2 (PAR2)
por: Das, Mitali, et al.
Publicado: (2022)

Zosteriform type in-transit metastasis of melanoma
por: Tas, Faruk
Publicado: (2016)

Emerging Roles of PAR-1 and PAFR in Melanoma Metastasis
por: Melnikova, Vladislava O., et al.
Publicado: (2008)

Patellar metastasis of melanoma
por: Tas, Faruk, et al.
Publicado: (2013)

Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2 α in cutaneous melanoma
por: Karjalainen, J M, et al.
Publicado: (2000)

Mining Database for the Clinical Significance and Prognostic Value of ESRP1 in Cutaneous Malignant Melanoma
por: Wang, Baihe, et al.
Publicado: (2020)

Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer
por: Liu, Xuan, et al.
Publicado: (2017)

Role of protease‐activated receptor‐1 (PAR‐1) in the glomerular filtration barrier integrity
por: Medipally, Ajay, et al.
Publicado: (2022)

Significance of metastatic topography for the immunotherapy of cutaneous and ocular melanomas
por: Săftescu, Sorin, et al.
Publicado: (2020)

Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma
por: Mao, Rui, et al.
Publicado: (2021)

The Diagnostic Significance of PDGF, EphA7, CCR5, and CCL5 Levels in Colorectal Cancer
por: Üçüncü, Muhammed, et al.
Publicado: (2019)

Complement factor C4a does not activate protease‐activated receptor 1 (PAR1) or PAR4 on human platelets
por: Han, Xu, et al.
Publicado: (2020)

Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors
por: Tas, Faruk
Publicado: (2012)

Developmental Role of Zebrafish Protease-Activated Receptor 1 (PAR1) in the Cardio-Vascular System
por: Ellertsdottir, Elin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4ts2l1mf4ju53fg8mphlps4gh0